Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 62.50B | 51.42B | 58.39B | 51.73B | 41.96B |
Gross Profit | 26.34B | 22.34B | 27.19B | 24.39B | 19.00B |
EBITDA | 14.27B | 10.78B | 14.97B | 13.72B | 9.33B |
Net Income | 9.43B | 6.50B | 10.59B | 9.16B | 5.61B |
Balance Sheet | |||||
Total Assets | 90.91B | 84.14B | 80.10B | 76.32B | 66.26B |
Cash, Cash Equivalents and Short-Term Investments | 27.86B | 34.93B | 36.24B | 36.56B | 31.32B |
Total Debt | 0.00 | 291.00M | 352.00M | 262.00M | 144.00M |
Total Liabilities | 14.01B | 11.57B | 11.09B | 13.35B | 10.17B |
Stockholders Equity | 76.12B | 72.58B | 69.01B | 62.97B | 56.09B |
Cash Flow | |||||
Free Cash Flow | 413.00M | 3.71B | 5.62B | 7.68B | 7.46B |
Operating Cash Flow | 12.99B | 7.45B | 7.38B | 9.30B | 8.74B |
Investing Cash Flow | -15.87B | -5.31B | -822.00M | -1.10B | -42.00M |
Financing Cash Flow | -5.64B | -5.64B | -6.14B | -3.83B | -2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥1.02T | 10.98 | 13.91% | 3.46% | 6.27% | 13.95% | |
79 Outperform | $8.42T | 52.18 | 34.01% | 0.34% | 60.27% | 158.92% | |
72 Outperform | ¥171.27B | 17.51 | 3.26% | 18.61% | 30.56% | ||
71 Outperform | ¥316.31B | 12.47 | 7.16% | 4.36% | 10.04% | -13.38% | |
71 Outperform | $663.57B | 20.25 | 3.69% | 4.30% | 3.40% | -35.47% | |
66 Neutral | ¥872.83B | 25.46 | 6.76% | 0.64% | -0.29% | 7.04% | |
63 Neutral | $34.70B | 4.89 | -11.39% | 1.66% | 5.53% | -19.00% |
Fujimi Incorporated reported significant growth in their financial performance for the nine months ending December 31, 2024, with a 23.9% increase in net sales and a substantial rise in operating profit by 48.3%. This financial improvement reflects positively on their market position, indicating a robust recovery from the previous period’s declines and a promising outlook for stakeholders.